Jin Medical International LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
Jin Medical International Ltd. amended its annual report on Form 20-F to address a material weakness in internal control over financial reporting and to restate its status as an accelerated filer.
NASDAQ
Jin Medical International Ltd. announces an 18.6% increase in revenue for fiscal year 2024, driven by new product lines and expanded production.
NASDAQ
Jin Medical International Ltd. confirms an underwriting agreement for a share offering, aiming to raise $8 million for corporate purposes.